[go: up one dir, main page]

HUE035778T2 - Polimixin származék és alkalmazásai - Google Patents

Polimixin származék és alkalmazásai

Info

Publication number
HUE035778T2
HUE035778T2 HUE16151398A HUE16151398A HUE035778T2 HU E035778 T2 HUE035778 T2 HU E035778T2 HU E16151398 A HUE16151398 A HU E16151398A HU E16151398 A HUE16151398 A HU E16151398A HU E035778 T2 HUE035778 T2 HU E035778T2
Authority
HU
Hungary
Prior art keywords
polymixin
derivative
applications
polymixin derivative
Prior art date
Application number
HUE16151398A
Other languages
English (en)
Inventor
Martti Vaara
Timo Vaara
Original Assignee
Northern Antibiotics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Antibiotics Oy filed Critical Northern Antibiotics Oy
Publication of HUE035778T2 publication Critical patent/HUE035778T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HUE16151398A 2015-01-15 2016-01-15 Polimixin származék és alkalmazásai HUE035778T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20155027A FI126143B (en) 2015-01-15 2015-01-15 Polymyxine derivative and its uses

Publications (1)

Publication Number Publication Date
HUE035778T2 true HUE035778T2 (hu) 2018-08-28

Family

ID=55310836

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16151398A HUE035778T2 (hu) 2015-01-15 2016-01-15 Polimixin származék és alkalmazásai

Country Status (19)

Country Link
EP (1) EP3045469B1 (hu)
JP (1) JP6471236B2 (hu)
KR (1) KR102020886B1 (hu)
CN (1) CN107207569B (hu)
AU (1) AU2016207942B2 (hu)
CA (1) CA2972743C (hu)
DK (1) DK3045469T3 (hu)
ES (1) ES2656562T3 (hu)
FI (1) FI126143B (hu)
HR (1) HRP20180180T1 (hu)
HU (1) HUE035778T2 (hu)
IL (1) IL253457B (hu)
MX (1) MX376475B (hu)
NO (1) NO3045469T3 (hu)
PT (1) PT3045469T (hu)
RU (1) RU2675819C1 (hu)
SG (1) SG11201705125UA (hu)
TW (1) TWI694087B (hu)
WO (1) WO2016113470A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017376711B2 (en) * 2016-12-16 2020-07-16 Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences Polymyxin derivative, preparation method and application thereof
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
CN107661349A (zh) * 2017-11-24 2018-02-06 刘晓峰 一种治疗小儿高热的联合用药物
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
IT201900025414A1 (it) 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
CN117083288A (zh) * 2021-03-31 2023-11-17 江苏奥赛康药业有限公司 一种多粘菌素衍生物的硫酸盐及其药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754411A (fr) * 1969-08-05 1971-02-04 Rhone Poulenc Sa Cyclopeptides derives des polymyxines et leur
TW274552B (hu) * 1992-05-26 1996-04-21 Hoechst Ag
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
CN103059106B (zh) * 2006-08-11 2015-01-14 北方抗生素有限公司 多粘菌素衍生物及其用途
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
KR20140091724A (ko) 2011-11-18 2014-07-22 노박타 바이오시스템스 리미티드 폴리믹신 유도체
JP6316846B2 (ja) * 2013-01-11 2018-04-25 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS ポリミキシン含有組成物
CA2939061C (en) 2013-05-22 2023-10-24 New Pharma Licence Holdings Limited Polymyxin derivatives and their use in combination therapy together with different antibiotics

Also Published As

Publication number Publication date
MX2017009094A (es) 2018-03-01
PT3045469T (pt) 2018-02-08
AU2016207942B2 (en) 2018-05-10
RU2675819C1 (ru) 2018-12-25
IL253457A0 (en) 2017-09-28
TWI694087B (zh) 2020-05-21
EP3045469B1 (en) 2017-11-29
FI126143B (en) 2016-07-15
WO2016113470A1 (en) 2016-07-21
JP2018505868A (ja) 2018-03-01
KR102020886B1 (ko) 2019-09-16
KR20170102005A (ko) 2017-09-06
DK3045469T3 (en) 2018-03-05
CN107207569B (zh) 2020-11-03
FI20155027A (fi) 2016-07-15
CN107207569A (zh) 2017-09-26
NO3045469T3 (hu) 2018-04-28
IL253457B (en) 2019-10-31
ES2656562T3 (es) 2018-02-27
AU2016207942A1 (en) 2017-08-10
CA2972743A1 (en) 2016-07-21
MX376475B (es) 2025-03-07
HRP20180180T1 (hr) 2018-03-09
JP6471236B2 (ja) 2019-02-13
BR112017014670A2 (pt) 2018-03-13
SG11201705125UA (en) 2017-07-28
EP3045469A1 (en) 2016-07-20
TW201630930A (zh) 2016-09-01
CA2972743C (en) 2020-06-09

Similar Documents

Publication Publication Date Title
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
HK1251587A1 (zh) 抗磷脂酰肌醇蛋白多糖-3的抗體及其應用
HK1252615A1 (zh) Il-8-結合抗體及其應用
HUE053737T2 (hu) Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik
HUE055755T2 (hu) Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk
HUE047255T2 (hu) Syntac polipeptidek és alkalmazásaik
HUE045307T2 (hu) EGFRVIII-ellenes antitestek és alkalmazásaik
HUE064791T2 (hu) APRIL ellenes antitest molekulák és alkalmazásaik
HUE061253T2 (hu) Antitestek OX40 ellen és azok felhasználásai
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
HUE054159T2 (hu) HPK1 gátlók és azok alkalmazási módja
HUE054339T2 (hu) CD73-ra specifikus kötõmolekulák és alkalmazásaik
HUE052771T2 (hu) C10orf54 elleni antitestek és alkalmazásuk
HUE043060T2 (hu) Triazolopirimidin-vegyületek és alkalmazásaik
HUE053619T2 (hu) Anti-CD123 antitestek és konjugátumok és ezek származékai
HUE057607T2 (hu) Pirazol-pirimidin-származék és annak felhasználása
HUE055233T2 (hu) Az EGFR gátló és annak elkészítése és alkalmazása
HUE048791T2 (hu) CD123 kötõszerek és alkalmazásaik
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
HUE059338T2 (hu) Ellenanyagok, alkalmazások és eljárások
CL2016002287A1 (es) Compuesto macrólido de seis miembros y aplicaciones del mismo
HUE059925T2 (hu) Módosított aminoacil-tRNS-szintetáz és alkalmazása
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
EP3481952A4 (en) METHYLATION MARKERS IN THE TREATMENT OF LEUKEMIA AND USES THEREOF
HUE035778T2 (hu) Polimixin származék és alkalmazásai